126 related articles for article (PubMed ID: 2146532)
1. Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome.
Spargo E; Luthert PJ; Anderton BH; Bruce M; Smith D; Lantos PL
Neurosci Lett; 1990 Jul; 115(2-3):345-50. PubMed ID: 2146532
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of an epitope specific to the neuron-specific isoform of human enolase recognised by a monoclonal antibody raised against a synthetic peptide corresponding to the C-terminus of beta/A4-protein.
Harrington CR; Quinn GB; Hurt J; Day IN; Wischik CM
Biochim Biophys Acta; 1993 Oct; 1158(2):120-8. PubMed ID: 7691181
[TBL] [Abstract][Full Text] [Related]
3. Beta A4 deposition in the temporal cortex of adults with Down's syndrome.
Spargo E; Luthert PJ; Janota I; Lantos PL
J Neurol Sci; 1992 Aug; 111(1):26-32. PubMed ID: 1402995
[TBL] [Abstract][Full Text] [Related]
4. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
5. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
6. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
Armstrong RA
Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
[TBL] [Abstract][Full Text] [Related]
7. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
[TBL] [Abstract][Full Text] [Related]
8. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
Mann DM; Yates PO; Marcyniuk B; Ravindra CR
J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
[TBL] [Abstract][Full Text] [Related]
9. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
[TBL] [Abstract][Full Text] [Related]
10. The spatial patterns of beta/A4 deposit subtypes in Down's syndrome.
Amstrong RA
Acta Neuropathol; 1994; 88(4):353-8. PubMed ID: 7839828
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid (beta/A4) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age.
Armstrong RA; Smith CU
Neurobiol Dis; 1994 Dec; 1(3):139-44. PubMed ID: 9173993
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
Glenner GG; Wong CW
Biochem Biophys Res Commun; 1984 Aug; 122(3):1131-5. PubMed ID: 6236805
[TBL] [Abstract][Full Text] [Related]
13. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
Ikeda S; Yanagisawa N; Allsop D; Glenner GG
Lab Invest; 1989 Jul; 61(1):133-7. PubMed ID: 2473275
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
[TBL] [Abstract][Full Text] [Related]
15. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
16. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome.
Cataldo AM; Barnett JL; Mann DM; Nixon RA
J Neuropathol Exp Neurol; 1996 Jun; 55(6):704-15. PubMed ID: 8642396
[TBL] [Abstract][Full Text] [Related]
17. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
[TBL] [Abstract][Full Text] [Related]
18. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
[No Abstract] [Full Text] [Related]
19. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.
van der Wal EA; Gómez-Pinilla F; Cotman CW
Neuroreport; 1993 Jan; 4(1):69-72. PubMed ID: 8453039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
